Public HealthTechnology

Obesity’s Outlook Unchanged

1 Mins read

Drugs for the clinical treatment of obesity have taken hits over the past year.  Denied regulatory approvals, market withdrawals and the resulting industry moves, if projected going forward, leave an overall negative impression of the market.  However, describing the “current” market for obesity drugs based on the “past as prologue” would be an incomplete picture.

Drugs for the clinical treatment of obesity have taken hits over the past year.  Denied regulatory approvals, market withdrawals and the resulting industry moves, if projected going forward, leave an overall negative impression of the market.  However, describing the “current” market for obesity drugs based on the “past as prologue” would be an incomplete picture.  Certainly, the attitude of the FDA in rejecting Arena’s Lorcaserin and Orexigen’s Contrave, as well the withdrawal by Abbott of Meridia and similar developments have tempered the “optimism” of obesity drug developers.  But optimism remains, stemming from an overwhelming need and therefore opportunity for obesity drugs.  

 

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019.” Report #S835 (copyright 2011, MedMarket Diligence, LLC).

Simultaneously, medical device development — restrictive devices, artificial fullness, malabsorption, gastric emptying, and appetite suppression devices — continue to see strong growth (i.e., double-digit CAGR) as approved devices see expanded indications (e.g., Lap Band) and new devices are steadily introduced to the market.

Surgical procedures and device implantation, however much they may avoid the challenges of drug complications (or just the FDA’s perceptions), are not free of challenges (including, of course, the need for surgery that is in many cases invasive), such as that there is a growing recognition that these are not permanent fixes and may require that expensive repeat procedures by done.

The short-term view of the obesity drug market is that it is “dead”, or at least on life support, but given the current market for obesity management products ($billions) and the indisputable accelerated growth in obesity prevalence and the recognition in the healthcare arena of obesity’s co-morbidity costs, one must conclude that the short-term view is not going to hold for very long at least not by many who are motivated by opportunity.

Avatar
183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Articles
Related posts
Health carePolicy & LawPublic HealthUncategorized

How Personal Injury Lawsuits Can Affect Your Relationship

3 Mins read
Accidents happen at the most unexpected time and place. When it does, victims suffer a personal injury that can have a long-lasting…
Covid-19Health careHospital AdministrationNursingPublic Health

The Future Of Nursing In A Post-Pandemic World

3 Mins read
Right now, it feels like life and work will never be the same again. Public spaces are severely restricted, lots of people…
Health carePublic Health

3 Important Tips To Reduce Health Insurance Costs

3 Mins read
Are you looking for ways to reduce your health insurance costs? Take a look at Medicare Advantage Plans 2021. Here are some…